Caris Life Sciences Inc. 2026年季度报告

CARIS LIFE SCIENCES, INC. Indicate by check mark whether the registrant (1) hasfiled all reports required to befiled by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required tofile such reports), Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuantto Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant Indicate by check mark whether the registrant is a large acceleratedfiler, an acceleratedfiler, a non-acceleratedfiler, a smaller reportingcompany, or an emerging growth company. See the definitions of “large acceleratedfiler,” “acceleratedfiler,” “smaller reporting Large acceleratedfiler☐Non-acceleratedfiler☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revisedfinancial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ As of May5, 2026, the registrant had 282,680,695 shares of common stock, par value $0.001 per share, outstanding. CARIS LIFE SCIENCES, INC.FORM 10-Q Table of Contents Special Note Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q (this “Quarterly Report”) contains forward-looking statements within the meaning of thePrivate Securities Litigation Reform Act of 1995 and other federal securities laws. All statements other than statements of historical factscontained in this Quarterly Report, including statements regarding our expectations of future results of operations andfinancialcondition, business strategy, future solutions, and launches of new solutions, technology, R&D costs, regulatory approvals, potentialmarket opportunity, anticipated trends in our business, timing and likelihood of success, as well as plans and objectives of management The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,”“predict,” “project,” “should,” “target,” “will,” or “would,” or the negative of these terms or other similar expressions, are intended to •developments in the precision medicine industry, including the market size for molecular information services and ourbiopharma partners’ use of molecular information;•our expectations as to our addressable U.S. market in oncology, futurefinancial performance, results of operations, or otheroperational results or metrics;•our ability to scale the Caris platform and develop and successfully launch new solutions or enhancements to existing solutions,as well as commercial market acceptance for our solutions, acceptance of preventive as well as diagnostic testing paradigms,and our ability to generate and meet demand for new and enhanced solutions;•our ability to capture, aggregate, analyze, or otherwise utilize molecular information in novel ways;•our ability to compete with companies that are currently in, or may in the future enter, the industry in which we operate;•third-party payer reimbursement and coverage decisions;•the ability of our solutions to help our biopharma partners and physicians improve the efficiency and success of theirtherapeutic development, and clinical programs;•our ability to establish, maintain, protect, enforce and enhance our intellectual property rights;•federal, state, and foreign regulatory requirements, including FDA regulation of our solutions, the timing, likelihood, or These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including those describedin the section titled “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2025 and in otherfilings we make with the Securities and Exchange Commission from time to time. Moreover, we operate in a competitive and rapidlychanging environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assessthe impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ Although we believe that the expectations reflected in our forward-looking statements are reasonable based on theinformation available to us when they are made, we cannot guarantee that the future results, advancements, discoveries, levels ofactivity, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur. In addition,statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements arebased upon information available to us as of the date of this Quarterly Report, and while we believe such